JP2009528390A5 - - Google Patents

Download PDF

Info

Publication number
JP2009528390A5
JP2009528390A5 JP2008557515A JP2008557515A JP2009528390A5 JP 2009528390 A5 JP2009528390 A5 JP 2009528390A5 JP 2008557515 A JP2008557515 A JP 2008557515A JP 2008557515 A JP2008557515 A JP 2008557515A JP 2009528390 A5 JP2009528390 A5 JP 2009528390A5
Authority
JP
Japan
Prior art keywords
latrunculin
aqueous
amount
preparation
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008557515A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009528390A (ja
Filing date
Publication date
Priority claimed from US11/680,893 external-priority patent/US7785624B2/en
Application filed filed Critical
Publication of JP2009528390A publication Critical patent/JP2009528390A/ja
Publication of JP2009528390A5 publication Critical patent/JP2009528390A5/ja
Withdrawn legal-status Critical Current

Links

JP2008557515A 2006-03-02 2007-03-02 薬用ラトランキュリン製剤 Withdrawn JP2009528390A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77927306P 2006-03-02 2006-03-02
US11/680,893 US7785624B2 (en) 2006-03-02 2007-03-01 Pharmaceutical latrunculin formulations
PCT/US2007/063171 WO2007103782A2 (en) 2006-03-02 2007-03-02 Pharmaceutical latrunculin formulations

Publications (2)

Publication Number Publication Date
JP2009528390A JP2009528390A (ja) 2009-08-06
JP2009528390A5 true JP2009528390A5 (https=) 2010-04-15

Family

ID=38475717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008557515A Withdrawn JP2009528390A (ja) 2006-03-02 2007-03-02 薬用ラトランキュリン製剤

Country Status (10)

Country Link
US (2) US7785624B2 (https=)
EP (1) EP1993563A4 (https=)
JP (1) JP2009528390A (https=)
KR (1) KR20080098636A (https=)
AU (1) AU2007223378A1 (https=)
BR (1) BRPI0708483A2 (https=)
CA (1) CA2644198A1 (https=)
MX (1) MX2008011112A (https=)
RU (1) RU2434633C2 (https=)
WO (1) WO2007103782A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010014240A2 (en) * 2008-07-29 2010-02-04 The Regents Of The University Of California Novel bioactive small molecules derived from sea sponges
US11254792B2 (en) 2015-12-29 2022-02-22 Galderma Holding SA Method for deacetylation of biopolymers
JP7386080B2 (ja) * 2016-08-02 2023-11-24 アンバー アイピー リミテッド 安定なイブプロフェン注射製剤用組成物
US20220047719A1 (en) * 2020-08-17 2022-02-17 Northwestern University Enhancing subcutaneous injection and target tissue accumulation of nanoparticles via co-administration with macropinocytosis inhibitory nanoparticles (minp)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2052950A1 (en) 1990-10-10 1992-04-11 David P. Evitts Aqueous ophthalmic microemulsions of tepoxalin
US5422116A (en) 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
US5798380A (en) 1996-02-21 1998-08-25 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
US6586425B2 (en) 1996-02-21 2003-07-01 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
JP3677421B2 (ja) * 1999-12-27 2005-08-03 扶桑薬品工業株式会社 涙液分泌促進組成物
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
CN101160315A (zh) * 2005-03-25 2008-04-09 印斯拜尔药品股份有限公司 细胞骨架的活性化合物，组合物及用途

Similar Documents

Publication Publication Date Title
JP2009528390A5 (https=)
PE20000433A1 (es) Formulacion farmaceutica en aerosol
CO5261563A1 (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
EP1312366A8 (en) Aqueous pharmaceutical compositions
PE20001499A1 (es) Composiciones farmaceuticas de n-benzoil-estaurosporina
AR078161A1 (es) Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
CZ302717B6 (cs) Vodný roztok meloxicamu
ATE390119T1 (de) Stabile benzimidazol zusammensetzungen
MX2011007689A (es) Una nueva crema dermaceutica hecha con fusidato de sodio, antifungicos y esteroides.
CO5160323A1 (es) Formulaciones farmaceuticas mejoradas vir en combinacion con otros inhibidores de proteasa vih
AR043106A2 (es) Formulaciones farmaceuticas para la administracion oral y topica y formas de dosis farmaceutica
RU2008139113A (ru) Фармацевтические препаративные формы латрункулина
US8362087B2 (en) Veterinary aqueous injectable suspensions containing florfenicol
JP2011098960A (ja) 水性組成物
JP6423353B2 (ja) 潰瘍性大腸炎の治療のための長期安定性を有する浣腸剤組成物
AR069831A1 (es) Composiciones y metodos para el tratamiento del cancer de vejiga
US20190046646A1 (en) Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists
KR20220104114A (ko) 안과용 조성물
JP6161500B2 (ja) ブロムフェナク含有組成物
WO2019117252A1 (ja) ２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸またはその塩を含有する点眼剤
CN104812370B (zh) 包含2-氨基-3-(4-溴苯甲酰基)苯基乙酸的含水液体组合物
KR20110096168A (ko) 푸시딘산나트륨을 사용하여 제조된 신규한 피부개선 크림
JPWO2016195057A1 (ja) ソフトカプセル剤
RU2014152454A (ru) Производное никотинамида в лечении острого коронарного синдрома
US11298360B2 (en) Ophthalmic compositions of brinzolamide